Krüppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells

Stem Cells
Chui-Wei WongShu-Chun Teng

Abstract

The zinc finger Krüppel-like transcription factor 4 (KLF4) has been implicated in cancer formation and stem cell regulation. However, the function of KLF4 in tumorigenesis and stem cell regulation are poorly understood due to limited knowledge of its targets in these cells. In this study, we have revealed a surprising link between KLF4 and regulation of telomerase that offers important insight into how KLF4 contributes to cancer formation and stem cell regulation. KLF4 sufficiently activated expression of the human telomerase catalytic subunit, human telomerase reverse transcriptase (hTERT), in telomerase-low alternative lengthening of telomeres (ALT), and fibroblast cells, while downregulation of KLF4 reduced its expression in cancerous and stem cells, which normally exhibits high expression. Furthermore, KLF4-dependent induction of hTERT was mediated by a KLF4 binding site in the proximal promoter region of hTERT. In human embryonic stem cells, expression of hTERT replaced KLF4 function to maintain their self-renewal. Therefore, our findings demonstrate that hTERT is one of the major targets of KLF4 in cancer and stem cells to maintain long-term proliferation potential.

References

May 31, 1990·Nature·C B HarleyC W Greider
Nov 6, 1998·Science·J A ThomsonJ M Jones
Feb 13, 1999·Nature Genetics·K J WuR Dalla-Favera
Jul 20, 1999·The Journal of Biological Chemistry·M A WaniJ B Lingrel
Nov 28, 2000·Annual Review of Genetics·M J McEachernE H Blackburn
Jan 1, 1996·Pathology Oncology Research : POR·John S McDonaldZlatko P Pavelic
Jul 10, 2001·The Journal of Biological Chemistry·J J Bieker
Sep 14, 2001·Human Molecular Genetics·M A CeroneS Bacchetti
Sep 27, 2001·Cell·E H Blackburn
Jul 31, 2003·Cell·Kenkichi MasutomiWilliam C Hahn
Jan 16, 2004·The Journal of Biological Chemistry·Shu-Chun TengKou-Juey Wu
Feb 26, 2004·Experimental Cell Research·Lin LiuDavid L Keefe
Oct 13, 2005·Carcinogenesis·Daoyan WeiKeping Xie
Mar 21, 2006·The Journal of Biological Chemistry·Hung-Ji TsaiShu-Chun Teng
Mar 28, 2006·Biochemical and Biophysical Research Communications·Loïc BlanchonVincent Sapin
Jun 15, 2006·Nature Reviews. Drug Discovery·Jerry W Shay, Woodring E Wright
Apr 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Sudeshna FischMukesh K Jain
Jun 8, 2007·Nature·Keisuke OkitaShinya Yamanaka
Sep 19, 2007·Nature Chemical Biology·Maria A Blasco
Dec 7, 2007·Nature Biotechnology·Masato NakagawaShinya Yamanaka
Feb 26, 2008·Nature Cell Biology·Muh-Hwa YangKou-Juey Wu
Mar 29, 2008·Cell Stem Cell·Matthias StadtfeldKonrad Hochedlinger
Sep 3, 2008·Oncogene·E VeraM A Blasco
Jan 20, 2009·Nature Biotechnology·Styliani MarkoulakiRudolf Jaenisch

❮ Previous
Next ❯

Citations

Aug 13, 2011·Cancer Chemotherapy and Pharmacology·Yongsheng JiaJinning Lou
Jan 4, 2012·Cell Research·Richard Allsopp
Oct 29, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jorge Organista-NavaPatricio Gariglio
Oct 29, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Sophie M Morgani, Joshua M Brickman
Feb 25, 2014·Protein & Cell·Yan HuangZhou Songyang
May 16, 2014·Science China. Life Sciences·Feng KongDaWei Xu
May 20, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Bo DingChun-Ling Wang
Dec 16, 2011·Cancer·Wen-Ting Yang, Peng-Sheng Zheng
Mar 22, 2016·Stem Cell Reports·Yoko Nakai-Futatsugi, Hitoshi Niwa
Oct 29, 2013·Biochemical and Biophysical Research Communications·Yuka FujiiTakashi Yokota
Jan 27, 2015·Journal of Physiology and Biochemistry·Yueling ZhangZhihe Zhao
Aug 3, 2016·Genes·Mukesh KumarÇagatay Güneş
Sep 14, 2016·Journal of Cancer Research and Clinical Oncology·Kenan IzgiBanu Iskender
Nov 2, 2016·Cancer Biomarkers : Section a of Disease Markers·Zhulin YangYuan Yuan
Oct 7, 2017·Nucleic Acids Research·Meng-Hsun HsiehShu-Chun Teng
Jun 15, 2018·International Journal of Molecular Sciences·Bidisha PaulTrygve O Tollefsbol
Sep 26, 2013·Nature Reviews. Cancer·Marie-Pier TetreaultJonathan P Katz
Dec 8, 2016·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Yin-Kai XueHai Zheng
Jan 28, 2020·International Journal of Radiation Biology·Kumari AnujaBirendranath Banerjee
Feb 13, 2019·International Journal of Radiation Biology·Kumari AnujaBirendranath Banerjee
Jul 28, 2019·Protein & Cell·Feng LiZhou Songyang
Mar 20, 2019·International Journal of Molecular Sciences·Alessandra VenturaMaria Concetta Fargnoli
Sep 10, 2020·Journal of Clinical Medicine·Taxiarchis Konstantinos NikolouzakisJohn Tsiaoussis
Feb 26, 2016·Journal of Leukocyte Biology·Chun Shik ParkH Daniel Lacorazza
Apr 15, 2021·Molecular Cell·Alex PenevAgnel Sfeir
Nov 30, 2011·Journal of Cell Science·Siim PauklinLudovic Vallier
Jun 3, 2021·Npj Aging and Mechanisms of Disease·Nicholas HolzscheckLars Kaderali

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.